Literature DB >> 17552010

Clinical presentation and genotype of hepatitis delta in Karachi.

Tariq Moatter1, Zaigham Abbas, Sabhita Shabir, Wasim Jafri.   

Abstract

AIM: To assess the clinical presentation and genotypes of delta hepatitis in local population.
METHODS: In this prospective study, 39 consecutive patients who were positive for HBsAg and hepatitis D virus (HDV) antibody were included. The patients were divided in two groups on the basis of presence or absence of HDV RNA and a comparative study was done. Genotype of HDV was determined in PCR positive patients.
RESULTS: Overall there is male dominance, in which 34 patients out of 39 (87.2%) were male. Twenty (51%) patients were from the adjacent areas of three provinces; Sindh, Punjab and Balochistan indicating the higher prevalence of delta hepatitis in this mid region of Pakistan. Patients of all age groups were affected with delta hepatitis (median 31.5 years, range 12-75). HDV RNA was detectable in 23 patients (59%). All the HDV strains belonged to genotype I. HBV DNA was detectable only in 3 cases who were also HBeAg and HDV RNA positive. Patients with detectable HDV RNA were younger than patients with undetectable RNA; mean age 29.7 +/- 12.8 years vs 36.8 +/- 15.2. There were no statistically significant differences in the clinical presentation and routine biochemical profile of patients with detectable or undetectable HDV RNA. Clinical cirrhosis was present in 19 (49%) patients; 12 with detectable RNA and 7 with undetectable HDV RNA (P = 0.748). Decompensated disease was seen in eight patients; five and three respectively from each group. Four patients with undetectable RNA and two patients with detectable RNA had normal ALT and ultrasound abdomen.
CONCLUSION: HDV may infect at any age, usually young adult males. Genotype I is prevalent. With time some of the patients become HDV RNA negative or asymptomatic carrier. Most of the patients have suppressed HBV DNA replication. Significant numbers of patients have cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17552010      PMCID: PMC4146823          DOI: 10.3748/wjg.v13.i18.2604

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

Review 1.  Delta hepatitis: an update.

Authors:  Patrizia Farci
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

2.  Hepatitis delta virus (HDV) genotypes in patients with chronic hepatitis: molecular epidemiology of HDV in Turkey.

Authors:  Imre Altuğlu; Tijen Ozacar; Ruchan Yazan Sertoz; Selda Erensoy
Journal:  Int J Infect Dis       Date:  2006-05-04       Impact factor: 3.623

3.  Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains.

Authors:  E Flodgren; S Bengtsson; M Knutsson; E A Strebkova; A H Kidd; O A Alexeyev; K Kidd-Ljunggren
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

Review 4.  Type B and D viral hepatitis: epidemiological changes in Southern Europe.

Authors:  G B Gaeta; G Stornaiuolo; D F Precone
Journal:  Forum (Genova)       Date:  2001 Apr-Jun

5.  Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt.

Authors:  Niveen Saudy; Fuminaka Sugauchi; Yasuhito Tanaka; Seiji Suzuki; Amina Abdel Aal; Mostafa Abo Zaid; Salah Agha; Masashi Mizokami
Journal:  J Med Virol       Date:  2003-08       Impact factor: 2.327

6.  Delta-infection and suppression of hepatitis B virus replication in chronic HBsAg carriers.

Authors:  K Krogsgaard; P Kryger; J Aldershvile; P Andersson; T I Sørensen; J O Nielsen
Journal:  Hepatology       Date:  1987 Jan-Feb       Impact factor: 17.425

7.  Interaction and replication activation of genotype I and II hepatitis delta antigens.

Authors:  Sheng-Chieh Hsu; Jaw-Ching Wu; I-Jane Sheen; Wan-Jr Syu
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment.

Authors:  M Rizzetto; G Verme; S Recchia; F Bonino; P Farci; S Aricò; R Calzia; A Picciotto; M Colombo; H Popper
Journal:  Ann Intern Med       Date:  1983-04       Impact factor: 25.391

9.  Acute and chronic hepatitis delta virus infection: direct or indirect effect on hepatitis B virus replication?

Authors:  P Farci; P Karayiannis; M E Lai; F Marongiu; G Orgiana; A Balestrieri; H C Thomas
Journal:  J Med Virol       Date:  1988-11       Impact factor: 2.327

10.  Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease.

Authors:  Hideki Watanabe; Kazuyoshi Nagayama; Nobuyuki Enomoto; Ryoko Chinzei; Tsuyoshi Yamashiro; Namiki Izumi; Hiroshi Yatsuhashi; Tatsunori Nakano; Betty H Robertson; Hiroki Nakasone; Hiroshi Sakugawa; Mamoru Watanabe
Journal:  J Gen Virol       Date:  2003-12       Impact factor: 3.891

View more
  9 in total

Review 1.  Hepatitis D Virus: Introduction and Epidemiology.

Authors:  Mario Rizzetto
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-01       Impact factor: 6.915

Review 2.  Hepatitis D: Scenario in the Asia-Pacific region.

Authors:  Zaigham Abbas; Wasim Jafri; Sajjad Raza
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

3.  Co-treatment with pegylated interferon alfa-2a and entecavir for hepatitis D: A randomized trial.

Authors:  Zaigham Abbas; Mohammad Sadik Memon; Muhammad Amir Umer; Minaam Abbas; Lubna Shazi
Journal:  World J Hepatol       Date:  2016-05-18

4.  Phylogenetic analysis of HDV isolates from HBsAg positive patients in Karachi, Pakistan.

Authors:  Shadab Perveen; Muhammad Israr Nasir; Syed M Shahid; Abid Azhar; Obaid Yusuf Khan
Journal:  Virol J       Date:  2012-08-15       Impact factor: 4.099

5.  Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis.

Authors:  Neda Amini; Seyed Moayed Alavian; Ali Kabir; Seyed Hossein Aalaei-Andabili; Seyed Yasser Saiedi Hosseini; Mario Rizzetto
Journal:  Hepat Mon       Date:  2013-01-06       Impact factor: 0.660

6.  Virological and clinical characteristics of hepatitis delta virus in South Asia.

Authors:  Khalid Mumtaz; Umair S Ahmed; Sadik Memon; Ali Khawaja; Muhammad T Usmani; Tariq Moatter; Saeed Hamid; Wasim Jafri
Journal:  Virol J       Date:  2011-06-20       Impact factor: 4.099

7.  Hepatocellular carcinoma in hepatitis D: does it differ from hepatitis B monoinfection?

Authors:  Zaigham Abbas; Mustafa Qureshi; Saeed Hamid; Wasim Jafri
Journal:  Saudi J Gastroenterol       Date:  2012 Jan-Feb       Impact factor: 2.485

8.  Prevalence and molecular characterization of hepatitis D virus in Saudi Arabia: A single-center study.

Authors:  Ghazi A Jamjoom; Mai M El-Daly; Esam I Azhar; Hind I Fallatah; Hisham O Akbar; Mohammed Babatin; Abdullah S Alghamdi; Mohammed I Dgdgi; Mohamed A Hamid; Yousef A Qari; Sherif A El-Kafrawy
Journal:  Saudi J Gastroenterol       Date:  2017 May-Jun       Impact factor: 2.485

9.  Frequency and Genotype of Hepatitis D Virus Infection in Patients Infected with HIV and Those Undergoing Hemodialysis.

Authors:  Mohammad Reza Aghasadeghi; Minoo Mohraz; Golnaz Bahramali; Arezoo Aghakhani; Mohammad Banifazl; Maryam Foroughi; Farrokhlagha Ahmadi; Ali Eslamifar; Seyed Mehdi Sadat; Amitis Ramezani
Journal:  Hepat Mon       Date:  2013-05-11       Impact factor: 0.660

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.